共 53 条
[1]
Pineo G.F.(2001)New developments in the prevention and treatment of venous thromboembolism Pharmacotherapy 21 S51-6
[2]
Weinmann E.E.(1994)Deep vein thrombosis N Engl J Med 331 1630-41
[3]
Salzman E.W.(2003)Duration of thromboembolism prophylaxis after surgery Chest 124 386S-2S
[4]
Kearon C.(1995)Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty Clin Orthop 321 19-27
[5]
Colwell C.W.(1994)Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement: a clinical trial comparing efficacy and safety J Bone Joint Surg Am 76 3-14
[6]
Spiro T.E.(1994)Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery Br J Surg 81 1742-6
[7]
Trowbridge A.A.(1998)Cost effectiveness of low molecular weight heparin and unfractionated heparin in the treatment of deep vein thrombosis CMAJ 159 931-8
[8]
Colwell C.W.(2000)Clinical outcome and cost of hospital vs. home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study Arch Intern Med 160 1769-73
[9]
Spiro T.E.(2000)Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs. warfarin in hip arthroplasty patients: a double-blind, randomized comparison Arch Intern Med 160 2199-207
[10]
Trowbridge A.A.(2000)Low-molecular-weight heparin prophylaxis using dalteparin extended out of hospital vs. in-hospital warfarin/out of hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison Arch Intern Med 160 2208-15